The German chemical producer Bayer has revised its projected results for 2001 downward on the back of production problems with one of its pharmaceutical products and the continuing slowdown in the world economy.

The company says it is no longer on target to repeat last year’s performance – the most successful in the company’s history - citing a sharp drop in earnings from its biotechnology product Konengate, a weakened world economy and high raw material costs.

Share this story: